Molecular Oncology

Tumor Suppressor Gene Inactivation Mechanisms

Investigation of molecular pathways through which TP53, RB, and PTEN genes lose function in cancer development and progression.

RESEARCH GAP FRONTIERS

Oncogenic Kinase Signaling Cascade Analysis

Comprehensive study of aberrant tyrosine and serine/threonine kinase signaling networks driving malignant transformation and metastasis.

RESEARCH GAP FRONTIERS

Epithelial-Mesenchymal Transition Regulation

Examination of molecular control mechanisms governing EMT processes and their role in cancer cell migration and invasion.

RESEARCH GAP FRONTIERS

Liquid Biopsy Biomarker Discovery

Development and validation of circulating tumor DNA, RNA, and protein markers for non-invasive cancer detection and monitoring.

RESEARCH GAP FRONTIERS

CRISPR-Cas9 Cancer Gene Editing

Application of genome editing technologies to identify essential cancer genes and develop therapeutic targeting strategies.

RESEARCH GAP FRONTIERS

Cancer Stem Cell Plasticity Dynamics

Study of molecular mechanisms controlling self-renewal, differentiation, and phenotypic switching in tumor-initiating cell populations.

RESEARCH GAP FRONTIERS

Immunotherapy Resistance Molecular Pathways

Investigation of genetic and epigenetic alterations conferring resistance to checkpoint inhibitor and CAR-T cell therapies.

RESEARCH GAP FRONTIERS

Hypoxia-Inducible Factor Signaling Networks

Analysis of HIF-mediated transcriptional programs driving angiogenesis, metabolic reprogramming, and tumor progression.

Chromosomal Instability and Aneuploidy

Molecular characterization of mechanisms generating chromosomal aberrations and their consequences for cancer evolution.

Metabolic Reprogramming in Malignancy

Study of altered glucose, lipid, and amino acid metabolism pathways enabling rapid tumor growth and survival.

DNA Mismatch Repair Deficiency

Investigation of MLH1, MSH2, and MSH6 inactivation leading to microsatellite instability and hypermutation phenotypes.

Extracellular Vesicle-Mediated Signaling

Characterization of exosome and microvesicle cargo and their role in intercellular communication within tumor microenvironments.

Viral Oncogenesis Molecular Mechanisms

Analysis of HPV, HBV, HCV, and EBV viral proteins driving malignant transformation through cellular signaling disruption.

Non-Coding RNA Cancer Regulation

Study of miRNA, lncRNA, and circRNA dysregulation in cancer initiation, progression, and therapeutic resistance.

Chromatin Remodeling Complex Dysfunction

Investigation of SWI/SNF, NuRD, and BAF complex alterations affecting epigenetic landscape and gene accessibility.

Wnt Pathway Hyperactivation Cancer

Molecular characterization of APC, CTNNB1, and LEF1 mutations driving aberrant Wnt signaling in intestinal and other cancers.

Notch Signaling in Hematologic Malignancies

Study of NOTCH1 and NOTCH3 activating mutations controlling T-cell lymphoma development and leukemic cell survival.

NF-Kappa B Activation in Cancer

Analysis of constitutive NF-κB pathway activation promoting inflammatory cytokine production and tumor cell survival.

Hedgehog Pathway Oncogenic Signaling

Investigation of PTCH1, SMO, and GLI mutations in medulloblastoma, basal cell carcinoma, and other malignancies.

PI3K-AKT-mTOR Axis Dysregulation

Comprehensive study of phosphatidylinositol 3-kinase pathway hyperactivation driving proliferation and survival in diverse cancers.

MAPK Signaling Pathway Activation

Molecular analysis of BRAF, KRAS, and MEK mutations driving sustained mitogen-activated protein kinase signaling in melanoma.

MicroRNA-Based Therapeutic Development

Design and validation of miRNA replacement and antagonist strategies for treating miRNA-dysregulated malignancies.

Angiogenesis and Vascular Targeting

Study of VEGF, FGF, and Angiopoietin signaling driving tumor neovascularization and development of anti-angiogenic therapies.

Tumor Microenvironment Cellular Interactions

Investigation of cancer-associated fibroblast, immune cell, and endothelial cell cross-talk in supporting tumor progression.

DNA Damage Response and Checkpoint Control

Analysis of ATM, ATR, and p53 checkpoint mechanisms and their failure in allowing genomic instability accumulation.

Telomerase Activation in Cancer Cells

Study of TERT promoter mutations and alternative lengthening of telomeres maintaining replicative immortality in tumors.

Cancer-Associated Fibroblast Activation

Investigation of mechanisms converting normal stromal fibroblasts into growth-promoting and immunosuppressive CAF populations.

Tumor-Associated Macrophage Polarization

Study of M1 to M2 macrophage polarization driven by IL-10, TGF-beta, and metabolic cues in tumor microenvironments.

MHC Class I Downregulation Mechanisms

Molecular characterization of immunoediting mechanisms allowing cancer cells to escape CD8+ T-cell recognition.

PD-L1 and B7-H3 Expression Regulation

Investigation of transcriptional and post-translational mechanisms controlling immune checkpoint ligand expression in tumors.

Genetic Polymorphisms Cancer Susceptibility

Genome-wide association studies identifying common genetic variants modulating cancer risk in population-based cohorts.

Hereditary Cancer Syndrome Mutations

Study of BRCA1, BRCA2, Lynch syndrome, and familial adenomatous polyposis mutations and their penetrance patterns.

Mutational Signature and Etiology

Decoding nucleotide substitution patterns to infer causative mutational processes including UV, smoking, and DNA repair defects.

Copy Number Variation Cancer Drivers

Identification and functional validation of recurrent amplifications and deletions driving oncogenic gene dosage imbalance.

Fusion Gene Oncogenic Mechanisms

Molecular characterization of ABL-BCR, EWS-FLI1, and other translocation-derived chimeric proteins in hematologic and solid tumors.

Long Non-Coding RNA Functional Studies

Investigation of HOTAIR, MALAT1, and other lncRNA mechanisms regulating chromatin structure and gene expression in cancer.

Enhancer-Driven Oncogene Activation

Study of super-enhancer remodeling and enhancer hijacking mechanisms activating MYC and other oncogenic transcriptional programs.

DNA Methylation and CpG Island Silencing

Analysis of aberrant CpG methylation inactivating tumor suppressors and its role as a cancer hallmark.

Histone Modification Dysregulation

Study of altered H3K4, H3K9, and H3K27 methylation patterns and histone acetylation in malignant transformation.

Metabolic Vulnerability and Synthetic Lethality

Identification of targetable metabolic dependencies in cancers with specific genetic alterations using systems biology approaches.

Tumor Heterogeneity and Clonal Evolution

Single-cell sequencing and multi-region sampling studies tracking clonal architecture and evolutionary trajectories in cancers.

Drug Resistance Mechanism Characterization

Molecular investigation of acquired mutations, epigenetic changes, and phenotypic switching conferring therapeutic resistance.

Targeted Therapy Biomarker Development

Discovery and validation of molecular predictors of response to kinase inhibitors, monoclonal antibodies, and targeted agents.

Combination Therapy Synergy Mechanisms

Study of molecular basis for synergistic interactions between targeted agents, immunotherapy, and conventional chemotherapy.

Cancer Dormancy and Minimal Residual Disease

Investigation of quiescence mechanisms allowing tumor cells to survive therapy and mediate late recurrence and metastasis.

Metastasis Initiating Cell Identification

Isolation and molecular characterization of cancer cells capable of colonizing distant sites and establishing secondary tumors.

Organ-Specific Tropism Mechanisms

Study of molecular determinants including adhesion molecules and chemokine receptors directing cancer cells to specific metastatic sites.

Bone Marrow Niche Interactions

Investigation of molecular crosstalk between leukemic blasts and bone marrow stromal cells supporting leukemia stem cell survival.

Artificial Intelligence Mutation Prediction

Machine learning models predicting oncogenic mutations and therapeutic responses from multi-omics cancer data integration.

High-Throughput Drug Screening Oncology

Large-scale pharmacogenomic profiling of cancer cell lines and patient-derived models identifying drug sensitivity patterns.

BRCA1/BRCA2 Homologous Recombination Deficiency

Investigation of mechanisms underlying BRCA mutation-driven homologous recombination repair failure and synthetic lethal therapeutic vulnerabilities in breast and ovarian cancers.

TP53 Pathway Inactivation and Cancer Progression

Molecular characterization of wild-type and mutant TP53 function in cancer initiation, progression, and chemotherapy resistance across multiple malignancies.

RB Pathway Disruption in Retinoblastoma

Analysis of retinoblastoma protein loss mechanisms and downstream cell cycle checkpoint dysregulation in pediatric and adult cancers.

PTEN Loss and PI3K Hyperactivation

Mechanistic study of phosphatase and tensin homolog inactivation driving phosphoinositide 3-kinase pathway activation in solid and hematologic malignancies.

KRAS Isoform-Specific Oncogenic Signaling

Comparative functional analysis of KRAS4A and KRAS4B variant-driven tumor initiation, maintenance, and therapeutic resistance mechanisms.

MYC Amplification and Transcriptional Addiction

Investigation of MYC-driven oncogenic transcriptional programs and dependencies exploitable for therapeutic intervention in high-grade malignancies.

ALK Fusion Kinase Aberrant Signaling

Structural and functional characterization of anaplastic lymphoma kinase fusion variants and acquired resistance mutations in lung cancer.

EGFR Mutation-Driven Pathway Activation

Molecular dynamics of epidermal growth factor receptor exon 19 deletions and L858R mutations driving ligand-independent signaling in adenocarcinoma.

HER2 Amplification and Therapeutic Resistance

Mechanistic analysis of human epidermal growth factor receptor 2 overexpression, heterodimerization, and escape from targeted antibody therapy.

BRAF V600E Melanoma Oncogenesis

Functional characterization of BRAF V600E-driven mitogen-activated protein kinase pathway hyperactivation and resistance to BRAF and MEK inhibition.

RET Rearrangement Medullary Thyroid Cancer

Molecular investigation of ret proto-oncogene rearrangements in hereditary and sporadic medullary thyroid carcinoma tumorigenesis.

JAK-STAT Pathway Aberrant Activation

Analysis of janus kinase and signal transducer and activator of transcription mutations driving cytokine-independent proliferation in hematologic malignancies.

STAT3 Oncogenic Homodimer Formation

Structural biology and functional studies of constitutively active STAT3 dimers promoting inflammation and immune evasion in cancer.

FLT3 Internal Tandem Duplication Leukemia

Characterization of fms-like tyrosine kinase 3 internal tandem duplication-induced receptor hyperdimerization and proliferative signaling in acute myeloid leukemia.

BCR-ABL Tyrosine Kinase Inhibitor Resistance

Molecular mechanisms of breakpoint cluster region-abelson leukemia viral oncogene homolog resistance including gatekeeper mutations and pathway bypass.

PML-RARA Fusion Acute Promyelocytic Leukemia

Mechanistic study of promyelocytic leukemia-retinoic acid receptor alpha fusion protein-driven aberrant differentiation and arsenic trioxide sensitivity.

EWS-FLI1 Fusion Ewing Sarcoma Transcription

Analysis of ewings sarcoma breakpoint region 1-friend leukemia integration 1 chimeric transcription factor driving oncogenic gene expression programs.

Proteasome Inhibition Resistance Mechanisms

Investigation of multiple myeloma and mantle cell lymphoma resistance to bortezomib and carfilzomib through altered proteasome composition.

Autophagy-Lysosomal Pathway Dysregulation

Study of oncogenic and tumor-suppressive autophagy mechanisms and their modulation as therapeutic targets in solid malignancies.

Unfolded Protein Response Cancer Addiction

Molecular characterization of endoplasmic reticulum stress-induced unfolded protein response activation supporting cancer cell survival and progression.

Ferroptosis Evasion in Cancer Cells

Investigation of iron-dependent regulated cell death suppression mechanisms and ferroptosis-inducing therapeutic strategies in resistant malignancies.

Pyroptosis and Inflammatory Cell Death

Study of inflammasome-mediated programmed cell death in cancer immunotherapy and its exploitation to enhance anti-tumor immunity.

Necroptosis Pathway Immune Activation

Analysis of receptor-interacting serine-threonine-protein kinase-mediated cell death and danger-associated molecular pattern release in cancer treatment.

Cancer Cell Acidic Microenvironment Adaptation

Molecular mechanisms of cancer cell survival and immune suppression in acidic tumor microenvironment through transporter and receptor modulation.

Fatty Acid Oxidation Cancer Metabolism

Investigation of carnitine palmitoyltransferase-dependent fatty acid oxidation as metabolic driver of cancer cell proliferation and therapeutic vulnerability.

Glutamine Addiction and GLS Dependency

Functional analysis of glutaminase-mediated glutamine catabolism supporting cancer cell biosynthesis and energy metabolism as druggable vulnerability.

One Carbon Metabolism Cancer Proliferation

Study of folate and methionine cycle contribution to nucleotide synthesis and methylation reactions driving cancer cell proliferation.

Nucleotide Biosynthesis and Cancer Growth

Mechanistic investigation of de novo purine and pyrimidine synthesis pathways as essential drivers and therapeutic targets in malignancy.

Amino Acid Transporter Mediated Uptake

Analysis of solute carrier family transporter-mediated amino acid uptake supporting cancer cell metabolic demands and tumor progression.

Lipid Synthesis and Cancer Membrane Dynamics

Investigation of sterol regulatory element-binding protein-driven lipogenesis and cholesterol metabolism supporting cancer cell proliferation and survival.

Lactate Metabolism and Immune Suppression

Study of lactate-mediated immunosuppression through monocarboxylate transporter signaling and GPR81 activation in tumor microenvironment.

Tumor-Extrinsic Immune Checkpoint Blockade

Molecular analysis of tumor-associated immune cell exhaustion reversal through CTLA-4, PD-1, and LAG-3 checkpoint receptor antagonism.

TIM-3 and TIGIT Immune Exhaustion

Investigation of T cell immunoglobulin and mucin domain-containing protein 3 and T cell immunoreceptor with Ig and ITIM domains signaling in cancer immunity.

Myeloid-Derived Suppressor Cell Differentiation

Characterization of myeloid-derived suppressor cell expansion and immunosuppressive effector function in tumor microenvironment.

Regulatory T Cell Recruitment and Function

Molecular study of FOXP3+ regulatory T cell homing, expansion, and suppressive cytokine production in tumor microenvironment.

B Cell Tertiary Lymphoid Structure Formation

Investigation of lymphoid neogenesis within tumors and its role in anti-tumor immunity and immunotherapy response prediction.

Natural Killer Cell Dysfunction Mechanisms

Molecular characterization of natural killer cell exhaustion and inhibitory receptor upregulation in immunologically cold tumors.

Complement System Tumor Microenvironment

Analysis of complement cascade activation and C5a-mediated immunosuppression in solid tumors and hematologic malignancies.

Transforming Growth Factor Beta Signaling

Study of transforming growth factor beta pathway-mediated epithelial-mesenchymal transition, fibroblast activation, and immune suppression in cancer.

Interleukin-6 Trans-Signaling Cancer

Mechanistic investigation of soluble interleukin-6 receptor-mediated trans-signaling promoting inflammation and cancer progression.

Chemokine Gradient Metastatic Dissemination

Analysis of C-C motif chemokine ligand and C-X-C motif chemokine ligand mediated recruitment of cancer cells to metastatic organs.

Angiopoietin-Tie Vascular Stabilization

Investigation of angiopoietin-tyrosine kinase with immunoglobulin and epidermal growth factor homology domains signaling in tumor angiogenesis regulation.

Vasculogenic Mimicry Cancer Progression

Study of plasma membrane domain formation by cancer cells enabling nutrient acquisition and immune escape in hypoxic tumors.

Venous Thromboembolism Cancer Coagulation

Molecular investigation of tissue factor-mediated procoagulant activity and cancer cell-derived microparticles driving thrombosis and metastasis.

Cancer-Associated Thrombosis PAR Signaling

Analysis of protease-activated receptor signaling in cancer cells and platelets promoting metastatic spread and immune suppression.

Perineural Invasion Molecular Mechanisms

Characterization of cancer cell-nerve interaction and neurotrophic factor-mediated nerve infiltration driving pain and metastatic progression.

Periostin Extracellular Matrix Remodeling

Investigation of periostin-integrin signaling in cancer-associated fibroblasts promoting desmoplasia and immunotherapy resistance.

Hyaluronic Acid Receptor CD44 Signaling

Study of cluster of differentiation 44-mediated hyaluronic acid binding and stemness properties in cancer stem cell populations.

Collagen Cross-Linking and Stiffness Sensing

Molecular analysis of lysyl oxidase-driven collagen cross-linking and mechanotransduction in desmoplastic tumor microenvironment.

Tenascin-C Stemness and Metastasis

Investigation of tenascin-C deposition in tumor niche and its role in cancer stem cell maintenance and metastatic colonization.

Protein Ubiquitination Cascade Cancer Regulation

Investigation of E3 ligase-mediated ubiquitin signaling pathways that drive oncogenic protein stability and degradation in malignant transformation.

Tumor-Intrinsic Interferons Type Response

Characterization of endogenous interferon signaling activation within cancer cells that modulates immunogenicity and therapeutic sensitivity.

STAT Transcription Factor Pathway Oncology

Analysis of signal transducer and activator of transcription hyperactivation driving cancer cell proliferation and immune suppression.

TGF-Beta Smad Signaling Cancer Progression

Examination of transforming growth factor-beta mediated Smad-dependent pathways promoting tumor progression and stromal remodeling.

Protein Aggregation Quality Control Oncology

Study of heat shock protein and proteasome dysfunction enabling malignant cells to tolerate proteotoxic stress and mutations.

AMPK-mTOR Metabolic Checkpoint Cancer

Investigation of AMP-activated protein kinase and mechanistic target of rapamycin balance controlling cancer cell metabolic fate.

Ferroptosis Iron Metabolism Cancer Vulnerability

Analysis of iron-dependent regulated cell death pathways as therapeutic targets for overcoming cancer drug resistance mechanisms.

Autophagy-Lysosomal Degradation Pathway Cancer

Characterization of macroautophagy and selective autophagy roles in cancer cell survival, metastasis, and therapeutic resistance.

Glutamine Metabolism Cancer Dependencies

Exploration of glutamine addiction and glutaminase-driven amino acid metabolism supporting oncogenic growth and proliferation.

One-Carbon Metabolism Epigenetic Cancer

Investigation of folate-dependent methyl transfer reactions regulating DNA methylation and histone modifications in malignancy.

Lipid Metabolism Membrane Dynamics Oncology

Study of aberrant cholesterol and phospholipid synthesis supporting cancer cell proliferation and metastatic dissemination.

Nucleotide Biosynthesis Cancer Cell Growth

Analysis of de novo purine and pyrimidine synthesis pathways essential for rapid cancer cell division and survival.

ROS Generation Redox Homeostasis Cancer

Characterization of reactive oxygen species production and antioxidant adaptation driving cancer progression and therapy resistance.

Alternative Splicing Isoform Cancer Function

Investigation of splicing factor dysregulation generating oncogenic protein isoforms and modulating tumor phenotypes.

RNA Modifications N6-Methyladenosine Cancer

Study of m6A methyltransferase and demethylase activity controlling RNA stability and translation in oncogenic contexts.

Phase Separation Oncogenic Transcription Hubs

Examination of biomolecular condensate formation driving super-enhancer assembly and oncogene transcriptional amplification.

Centrosome Amplification Mitotic Catastrophe

Analysis of centrosome dysregulation leading to multipolar mitosis, genomic instability, and tumor cell death mechanisms.

G-Quadruplex Stabilization Genome Instability

Investigation of G-quadruplex secondary structures at telomeres and oncogene promoters driving chromosomal rearrangements.

Homologous Recombination Deficiency Therapeutic

Study of BRCA1/BRCA2 mutations and RAD51 pathway defects enabling synthetic lethal drug sensitivities.

Non-Homologous End Joining Cancer

Characterization of error-prone DNA repair pathway dysregulation generating oncogenic chromosomal translocations and fusions.

Base Excision Repair Cancer Progression

Investigation of oxidative DNA damage repair deficiency accumulating mutations and driving malignant transformation.

Nucleotide Excision Repair Carcinogen Sensitivity

Analysis of nucleotide excision repair pathway dysfunction increasing vulnerability to environmental carcinogen-induced damage.

Death Receptor Extrinsic Apoptosis Cancer

Study of Fas, TRAIL, and TNF receptor signaling evasion mechanisms enabling cancer cell survival and immune escape.

Intrinsic Mitochondrial Apoptosis BCL2

Examination of BCL2 family protein imbalance and mitochondrial outer membrane permeabilization in cancer cell apoptosis resistance.

Necroptosis RIPK Pathway Cancer Immunity

Investigation of receptor-interacting serine/threonine kinase-mediated programmed necrosis as immunogenic cell death cancer therapy.

Pyroptosis NLRP3 Inflammasome Oncology

Characterization of caspase-1 mediated inflammatory pyroptosis and inflammasome activation in cancer immunotherapy contexts.

Immune Checkpoint Ligand Sialic Acid

Analysis of glycosylation and sialylation modifications masking immune epitopes and augmenting PD-L1 checkpoint engagement.

T Cell Exhaustion Molecular Markers

Study of LAG3, TIM3, and TOX transcription factor expression defining dysfunctional tumor-infiltrating T lymphocyte states.

Regulatory T Cell Tumor Suppression

Investigation of FOXP3+ regulatory T cell recruitment and immunosuppressive cytokine production in tumor microenvironments.

Natural Killer Cell Exhaustion Cancer

Examination of natural killer cell dysfunction mediated by tumor-derived IL-10 and TGF-beta immunosuppression.

Myeloid-Derived Suppressor Cell Differentiation

Characterization of STAT3 and S100A8/A9 mediated myeloid-derived suppressor cell expansion and immunosuppressive functions.

B Cell Lymphoma Germinal Center

Investigation of abnormal germinal center reactions and B cell receptor signaling driving lymphoid malignancy development.

T Cell Receptor Clonal Selection

Study of oncogenic T cell receptor rearrangement mechanisms and clonal expansion in T cell lymphomas.

Immunoglobulin Gene Rearrangement Cancer

Analysis of class switch recombination errors and V(D)J recombination dysregulation causing lymphoid malignancies.

Epstein-Barr Virus Lymphoma Latency

Examination of EBV latent gene products EBNA and LMP driving B cell immortalization and lymphomagenesis.

Human Papillomavirus Oncogenic Proteins

Investigation of HPV E6 and E7 oncoproteins disrupting p53 and RB tumor suppressor pathways in cervical cancer.

Hepatitis B Virus HBx Oncogenesis

Study of hepatitis B virus X antigen driven hepatocellular carcinoma through p53 inactivation and genomic instability.

Hepatitis C Virus Core Protein

Characterization of hepatitis C virus structural protein effects on oxidative stress and cellular transformation mechanisms.

Human T Lymphotropic Virus HTLV-1

Analysis of HTLV-1 Tax protein mediated NF-kappa B activation and ATLL leukemia development.

Kaposi Sarcoma Herpesvirus LANA Oncology

Investigation of KSHV latency-associated nuclear antigen effects on CTNNB1 and cell cycle dysregulation.

Promoter-Proximal Pausing Transcriptional Control

Study of BRD4 and P-TEFb mediated release of paused polymerase II controlling oncogene expression bursts.

Super-Enhancer Driven Oncogene Addiction

Examination of cancer-specific super-enhancer architecture driving MYC, KRAS, and other oncogenic dependencies.

Silencer Element Cancer Gene Suppression

Characterization of disrupted silencer elements enabling oncogenic transcription and tumor suppressor gene silencing.

Insulator CTCF Chromatin Looping

Investigation of CCCTC-binding factor insulator dysfunction causing aberrant oncogene and tumor suppressor interactions.

Polycomb Complex H3K27me3 Silencing

Analysis of polycomb repressive complex mediated H3K27 trimethylation driving tumor suppressor gene silencing.

MLL Complex H3K4me3 Activation Cancer

Study of mixed lineage leukemia complex mediated H3K4 trimethylation driving oncogenic gene activation.

Phosphatidylinositol Lipid Signaling Cancer

Investigation of phosphoinositide kinase dysregulation and PIP3-dependent AKT pathway hyperactivation in malignancy.

Calcium Signaling STIM1 Cancer

Characterization of store-operated calcium entry dysregulation and NFAT activation in cancer cell proliferation.

Wnt Ligand Frizzled Signalosome Assembly

Study of Wnt ligand palmitoylation and secretory pathway dysregulation in beta-catenin independent cancer signaling.

Sonic Hedgehog Ligand Dependent Cancer

Investigation of autocrine Sonic Hedgehog signaling driving developmental pathway reactivation in adult malignancies.

Proteolytic Processing Cancer Cell Signaling

Investigation of protease-mediated cleavage events regulating oncogenic signaling cascades and tumor progression.

Glutamine Metabolism Tumor Growth Dependencies

Analysis of glutaminolysis pathways as essential metabolic vulnerabilities in diverse malignancy types.

Ferroptosis Induction Cancer Therapeutics

Development of iron-dependent cell death mechanisms as novel targeted cancer treatment modalities.

Autophagy Flux Modulation Drug Response

Characterization of autophagic pathway dynamics regulating chemotherapy sensitivity and resistance phenotypes.

Ubiquitin-Proteasome System Oncogenic Signaling

Study of E3 ligase-mediated protein degradation controlling cancer-promoting signal transduction networks.

SUMO Modification Nuclear Protein Regulation

Investigation of SUMOylation events controlling transcription factor activity and cancer cell phenotypes.

RNA m6A Methylation Cancer Progression

Analysis of N6-methyladenosine modifications regulating mRNA stability and oncogenic protein expression.

RNA Secondary Structure Oncogenic Translation

Examination of RNA structural motifs regulating internal ribosome entry and proto-oncogene translation.

Phase Separation Condensate Formation Oncology

Study of biomolecular condensates organizing transcriptional and signaling hubs driving malignant transformation.

DNA Damage Tolerance Replication Fidelity

Analysis of error-prone DNA polymerase mechanisms enabling cancer cells to bypass checkpoint controls.

Homologous Recombination Deficiency Exploitation

Development of PARP inhibitor and platinum-based therapies targeting HR-deficient tumor cells.

Base Excision Repair Genomic Instability

Investigation of BER pathway impairment contributing to mutation accumulation and cancer development.

Nucleotide Excision Repair UV-Induced Malignancy

Study of NER deficiency mechanisms underlying xeroderma pigmentosum and skin cancer susceptibility.

Mismatch Repair Microsatellite Instability Immunotherapy

Characterization of MMR-deficient tumors with high mutational burden as immunotherapy-responsive cancers.

p53 Mutational Landscape Isoform Function

Comprehensive analysis of p53 mutations and alternative protein isoforms affecting tumor suppression capacity.

Rb Pathway Inactivation Cell Cycle Deregulation

Investigation of retinoblastoma protein loss enabling uncontrolled G1-S phase progression in cancers.

BRCA1 BRCA2 Homologous Recombination Cancer

Study of germline BRCA mutations affecting DNA repair capacity and hereditary cancer predisposition.

TP53 Family p63 p73 Isoforms

Analysis of p53 family member functions and their isoforms in tumor suppression and differentiation.

Loss of Heterozygosity Tumor Suppressors

Investigation of allelic imbalance and haploinsufficiency mechanisms in two-hit tumor suppressor genes.

Inactivating Mutations PTEN Phosphatase

Characterization of PTEN loss affecting PI3K-AKT pathway hyperactivation and cancer progression.

NF1 Neurofibromin Pathway Inactivation

Study of NF1 mutations and GAP-mediated RAS deregulation in neurofibromatosis malignancies.

APC Adenomatous Polyposis Coli Functions

Analysis of APC loss affecting Wnt signaling dysregulation and colorectal cancer initiation.

Succinate Dehydrogenase Complex Dysfunction

Investigation of SDH mutations in paragangliomas and associated metabolic reprogramming mechanisms.

Isocitrate Dehydrogenase Neomorphic Activity

Study of IDH mutations producing 2-hydroxyglutarate oncometabolite and epigenetic remodeling in gliomas.

MYC Oncogene Transcriptional Network

Comprehensive characterization of MYC amplification effects on global gene expression and metabolism.

KRAS Mutation Allele-Specific Dependencies

Investigation of G12C G12V G12D KRAS mutations conferring distinct oncogenic and therapeutic vulnerabilities.

BRAF V600E Melanoma MAPK Signaling

Analysis of BRAF V600E mutation driving MAPK pathway hyperactivation and vemurafenib resistance mechanisms.

ALK Rearrangement Tyrosine Kinase Oncogene

Study of ALK fusion partners and kinase domain mutations affecting crizotinib response and resistance.

ROS1 Gene Fusion Lung Cancer Drivers

Characterization of ROS1 fusion oncoproteins and therapeutic strategies targeting rearranged kinase signaling.

EGFR Mutation Subtypes Tyrosine Kinase Inhibitor

Analysis of L858R and exon 19 deletion EGFR mutations determining erlotinib and gefitinib sensitivity.

HER2 Amplification Breast Cancer Biology

Investigation of HER2 overexpression mechanisms and resistance to trastuzumab-based immunotherapy combinations.

FGFR Tyrosine Kinase Family Signaling

Study of FGFR1-4 mutations and gene fusions driving autocrine signaling and fibroblast growth factor dependence.

SRC Family Kinase Non-Receptor Signaling

Investigation of SRC YES and FYN kinases promoting invasion metastasis and therapeutic resistance.

BCR-ABL Fusion Protein Chronic Myeloid Leukemia

Characterization of BCR-ABL oncogenic fusion kinase and mechanisms of imatinib resistance mutations.

PML-RARA Nuclear Receptor Acute Promyelocytic Leukemia

Analysis of PML-RARA fusion affecting differentiation and all-trans retinoic acid arsenic trioxide response.

NUP98 Translocations Acute Leukemia Transcription

Investigation of NUP98 fusion partners disrupting HOX gene regulation and hematopoietic transformation.

EWSR1-FLI1 Fusion Ewing Sarcoma Oncology

Study of Ewing sarcoma-defining EWSR1-FLI1 fusion transcription factor and ETS family interactions.

PAX-FOXO1 Alveolar Rhabdomyosarcoma Transcription

Characterization of PAX3-FOXO1 and PAX7-FOXO1 fusion oncogenes in rhabdomyosarcoma differentiation.

SS18-SSX Chromatin Remodeling Synovial Sarcoma

Analysis of SS18 BAF complex disruption and SSX-mediated transcriptional reprogramming in synovial sarcoma.

Zinc Finger Protein Family Transcriptional Dysregulation

Investigation of zinc finger domain mutations and deletions affecting DNA binding and cancer cell identity.

Helicase Domain Mutations DNA Unwinding Defects

Study of helicases like RECQL and BLM dysfunction causing genomic instability and cancer predisposition.

Bromodomain and Extraterminal Inhibition Transcription

Characterization of BET protein acetyl-lysine recognition and BRD4 inhibition in cancer therapeutics.

SWI-SNF Complex Mutations Cancer Spectrum

Investigation of ARID1A ARID1B and BRG1 mutations causing chromatin accessibility changes across malignancies.

Polycomb Repressive Complex Silencing Functions

Analysis of PRC1 and PRC2 mutations dysregulating H3K27 trimethylation and gene silencing patterns.

SETD2 Histone Methyltransferase Renal Cell Carcinoma

Study of SETD2 H3K36me3 loss affecting DNA repair and renal cancer susceptibility.

EZH2 Enhancer of Zeste 2 Lymphomas

Characterization of EZH2 gain-of-function mutations and Y646 substitutions in diffuse large B-cell lymphoma.

Histone Deacetylase Inhibitor Cancer Epigenetics

Investigation of HDAC1-11 isoforms and class-specific inhibition strategies in malignant transformation.

DNA Methyltransferase DNMT3 Epigenetic Priming

Analysis of de novo DNMT3A DNMT3B mutations affecting methylation patterns and leukemia development.

Ten-Eleven Translocation Enzyme DNA Demethylation

Study of TET1-3 mutations impairing 5-methylcytosine oxidation and epigenetic reprogramming capacity.

Argonaute Protein RISC Complex Assembly

Investigation of AGO1-4 proteins mediating miRNA binding and translational silencing of oncogenes.